Free Trial

Allogene Therapeutics (ALLO) Institutional Ownership

Allogene Therapeutics logo
$2.17 -0.09 (-3.98%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$2.17 0.00 (0.00%)
As of 02/21/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Allogene Therapeutics (NASDAQ:ALLO)

Current
Institutional Ownership
Percentage
83.63%
Number of
Institutional Buyers
(last 12 months)
73
Total
Institutional Inflows
(last 12 months)
$68.06M
Number of
Institutional Sellers
(last 12 months)
35
Total
Institutional Outflows
(last 12 months)
$20.21M
Get ALLO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Allogene Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ALLO Institutional Buying and Selling by Quarter

Allogene Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2025 Navalign LLC59,865$128K0.0%-20.6%0.029%
2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC270,559$576K0.0%+18.2%0.129%
2/17/2025 Squarepoint Ops LLC20,345$43K0.0%-89.2%0.010%
2/17/2025 Two Sigma Advisers LP2,702,200$5.76M0.0%+12.1%1.289%
2/17/2025 Two Sigma Investments LP2,712,139$5.78M0.0%-3.1%1.294%
2/17/2025 Tidal Investments LLC135,952$290K0.0%-4.8%0.065%
2/17/2025 Rafferty Asset Management LLC367,445$783K0.0%+15.9%0.175%
2/17/2025 Raiffeisen Bank International AG430,000$903K0.0%N/A0.205%
2/17/2025 ProShare Advisors LLC46,082$98K0.0%+25.6%0.022%
2/17/2025 Patient Square Capital LP1,489,909$3.17M1.2%N/A0.711%
2/17/2025 Nuveen Asset Management LLC300,871$641K0.0%+18.3%0.143%
2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.305,895$651K0.0%+23.6%0.146%
2/17/2025 Graham Capital Management L.P.41,737$89K0.0%N/A0.020%
2/17/2025 Coastal Bridge Advisors LLC221,059$471K0.1%-45.5%0.105%
2/17/2025 D. E. Shaw & Co. Inc.54,517$116K0.0%-39.6%0.026%
2/17/2025 DAFNA Capital Management LLC1,240,118$2.64M0.7%+18.1%0.591%
2/17/2025 Caption Management LLC15,000$32K0.0%N/A0.007%
2/17/2025 Brevan Howard Capital Management LP87,573$187K0.0%+38.9%0.042%
2/17/2025 Caxton Associates LP206,380$440K0.0%-14.8%0.098%
2/17/2025 Bank of America Corp DE1,163,743$2.48M0.0%+99.3%0.555%
2/17/2025 BNP Paribas Financial Markets849,658$1.81M0.0%+1,732.2%0.405%
2/17/2025 Ameriprise Financial Inc.201,943$430K0.0%+14.0%0.096%
2/14/2025 Jane Street Group LLC164,523$350K0.0%-63.5%0.078%
2/14/2025 Foresite Capital Management VI LLC3,448,275$7.35M3.3%N/A1.645%
2/14/2025 Northern Trust Corp1,305,232$2.78M0.0%+4.5%0.623%
2/14/2025 Lynx1 Capital Management LP10,874,723$23.16M8.7%+75.3%5.187%
2/14/2025 Susquehanna Fundamental Investments LLC376,661$802K0.0%N/A0.180%
2/14/2025 Syon Capital LLC18,351$39K0.0%N/A0.009%
2/14/2025 Price T Rowe Associates Inc. MD4,485,572$9.56M0.0%-7.3%2.139%
2/14/2025 Hsbc Holdings PLC69,155$147K0.0%+32.0%0.033%
2/14/2025 MetLife Investment Management LLC38,020$81K0.0%-28.5%0.018%
2/14/2025 Dimensional Fund Advisors LP3,561,626$7.59M0.0%+30.4%1.699%
2/14/2025 Gilead Sciences Inc.1,156,689$2.46M0.2%N/A0.552%
2/13/2025 Zacks Investment Management480,874$1.02M0.0%-6.9%0.229%
2/13/2025 XTX Topco Ltd158,537$338K0.0%N/A0.076%
2/13/2025 Barclays PLC761,286$1.62M0.0%+122.0%0.363%
2/13/2025 Renaissance Technologies LLC554,541$1.18M0.0%-13.6%0.264%
2/13/2025 Legal & General Group Plc112,235$239K0.0%-11.9%0.054%
2/13/2025 Invesco Ltd.127,486$272K0.0%+7.0%0.061%
2/13/2025 Cerity Partners LLC387,387$832K0.0%-10.4%0.185%
This Crypto Is Set to Explode in February (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

2/13/2025 Wells Fargo & Company MN104,593$223K0.0%+29.4%0.050%
2/12/2025 PAX Financial Group LLC12,832$27K0.0%N/A0.006%
2/12/2025 RPO LLC14,787$31K0.0%N/A0.007%
2/12/2025 JPMorgan Chase & Co.3,736,132$7.96M0.0%-8.6%1.782%
2/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.253,576$548K0.0%+7.1%0.121%
2/11/2025 Vanguard Group Inc.8,000,692$17.04M0.0%-3.9%3.816%
2/11/2025 KLP Kapitalforvaltning AS20,400$43K0.0%N/A0.010%
2/11/2025 Sei Investments Co.48,320$103K0.0%N/A0.023%
2/11/2025 American Century Companies Inc.232,356$495K0.0%+16.5%0.111%
2/11/2025 Teacher Retirement System of Texas43,877$93K0.0%+28.9%0.021%
2/11/2025 Intech Investment Management LLC71,323$152K0.0%+72.6%0.034%
2/10/2025 Primecap Management Co. CA4,927,340$10.50M0.0%-13.1%2.350%
2/10/2025 Cibc World Markets Corp12,013$26K0.0%N/A0.006%
2/10/2025 Swiss National Bank287,900$613K0.0%+8.7%0.137%
2/7/2025 HighTower Advisors LLC12,150$26K0.0%-59.0%0.006%
2/6/2025 Charles Schwab Investment Management Inc.1,188,838$2.53M0.0%+0.8%0.567%
2/4/2025 Bank of New York Mellon Corp330,769$705K0.0%+4.1%0.158%
1/31/2025 Partners Capital Investment Group LLP93,248$199K0.0%-63.4%0.044%
1/30/2025 Rhumbline Advisers191,714$408K0.0%+10.1%0.091%
1/30/2025 Vontobel Holding Ltd.195,457$416K0.0%+788.4%0.093%
1/24/2025 abrdn plc364,382$776K0.0%N/A0.174%
1/17/2025 Bourgeon Capital Management LLC118,700$253K0.0%-16.7%0.057%
1/6/2025 Nordea Investment Management AB460,641$986K0.0%+2.1%0.220%
12/26/2024 JPMorgan Chase & Co.4,087,506$11.45M0.0%-0.9%1.949%
11/25/2024 Tidal Investments LLC142,747$400K0.0%-39.7%0.068%
11/19/2024 Barclays PLC342,973$959K0.0%+101.5%0.164%
11/16/2024 Geode Capital Management LLC3,227,104$9.04M0.0%+14.4%1.539%
11/15/2024 Barclays PLC342,973$959K0.0%+101.5%0.164%
11/15/2024 MML Investors Services LLC20,000$56K0.0%N/A0.010%
11/15/2024 Zacks Investment Management516,601$1.45M0.0%N/A0.246%
11/15/2024 EP Wealth Advisors LLC24,475$69K0.0%+125.6%0.012%
11/15/2024 State Street Corp7,013,083$19.64M0.0%-8.5%3.345%
11/15/2024 Erste Asset Management GmbH31,400$91K0.0%N/A0.015%
11/14/2024 Vestal Point Capital LP1,500,000$4.20M0.3%-31.8%0.715%
11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC228,806$641K0.0%-14.2%0.109%
11/14/2024 MetLife Investment Management LLC53,147$149K0.0%-10.1%0.025%
11/13/2024 BNP Paribas Financial Markets46,374$130K0.0%+541.5%0.022%
11/13/2024 FMR LLC30,026,956$84.08M0.0%-3.9%14.321%
11/13/2024 The Manufacturers Life Insurance Company486,023$1.36M0.0%+1.2%0.232%
11/9/2024 Intech Investment Management LLC41,331$116K0.0%N/A0.020%
11/6/2024 Cornercap Investment Counsel Inc.28,533$80K0.0%-55.0%0.014%
11/6/2024 Curi RMB Capital LLC149,577$419K0.0%+47.5%0.072%
10/25/2024 China Universal Asset Management Co. Ltd.40,219$113K0.0%+64.0%0.019%
10/22/2024 Private Advisor Group LLC12,087$34K0.0%N/A0.006%
10/11/2024 Creative Planning61,396$172K0.0%+108.7%0.029%
10/10/2024 Exchange Traded Concepts LLC60,675$170K0.0%+25.5%0.029%
10/3/2024 SG Americas Securities LLC46,967$132K0.0%+252.7%0.022%
8/16/2024 Perceptive Advisors LLC2,725,000$6.35M0.2%N/A1.304%
8/16/2024 Algert Global LLC14,808$35K0.0%N/A0.007%
8/15/2024 Susquehanna Fundamental Investments LLC418,699$976K0.0%+46.2%0.200%
Buy this AI Stock Before Elon’s Announcement (Ad)

With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dust. This isn't just a prediction; it's a calculated shift backed by political support, policy changes, and Musk's proven track record. I've identified a company that is quietly enabling xAI's rapid growth.

Click here to watch my presentation and learn how to invest today.
8/15/2024 Lynx1 Capital Management LP2,228,295$5.19M1.9%N/A1.066%
8/15/2024 The Manufacturers Life Insurance Company480,381$1.12M0.0%+70.3%0.230%
8/15/2024 AQR Capital Management LLC27,287$64K0.0%N/A0.013%
8/15/2024 Caxton Associates LP466,110$1.09M0.0%+8.1%0.223%
8/14/2024 Squarepoint Ops LLC126,628$295K0.0%N/A0.061%
8/14/2024 Profund Advisors LLC76,160$177K0.0%-37.1%0.036%
8/12/2024 Hsbc Holdings PLC44,664$103K0.0%-17.5%0.021%
8/12/2024 E Fund Management Co. Ltd.25,333$59K0.0%-31.8%0.012%
8/9/2024 Primecap Management Co. CA5,670,226$13.21M0.0%+4.1%2.713%
8/9/2024 Renaissance Technologies LLC1,747,955$4.07M0.0%+340.4%0.836%
(Data available from 1/1/2016 forward)

ALLO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ALLO shares?

During the previous two years, 135 institutional investors and hedge funds held shares of Allogene Therapeutics. The most heavily invested institutionals were FMR LLC ($84.08M), Lynx1 Capital Management LP ($23.16M), State Street Corp ($19.64M), Vanguard Group Inc. ($17.04M), Primecap Management Co. CA ($10.50M), Price T Rowe Associates Inc. MD ($9.56M), and Geode Capital Management LLC ($9.04M).Learn more on ALLO's institutional investors.

What percentage of Allogene Therapeutics stock is owned by institutional investors?

83.63% of Allogene Therapeutics stock is owned by institutional investors. Learn more on ALLO's institutional investor holdings.

Which institutional investors have been buying Allogene Therapeutics stock?

Of the 115 institutional investors that purchased Allogene Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Lynx1 Capital Management LP ($6.90M), Foresite Capital Management VI LLC ($3.45M), Vanguard Group Inc. ($3.09M), Perceptive Advisors LLC ($2.73M), Price T Rowe Associates Inc. MD ($1.81M), Baker BROS. Advisors LP ($1.58M), and Patient Square Capital LP ($1.49M).

How much institutional buying is happening at Allogene Therapeutics?

Institutional investors have bought a total of 39,593,264 shares in the last 24 months. This purchase volume represents approximately $113.88M in transactions.

Which Allogene Therapeutics major shareholders have been selling company stock?

Of the 48 institutional investors that sold Allogene Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: FMR LLC ($1.23M), Vanguard Group Inc. ($1.15M), Primecap Management Co. CA ($1.10M), ExodusPoint Capital Management LP ($730.95K), Vestal Point Capital LP ($700K), State Street Corp ($655.04K), and BNP Paribas Financial Markets ($510.14K).

How much institutional selling is happening at Allogene Therapeutics?

Institutional investors have sold a total of 9,446,520 shares in the last 24 months. This volume of shares sold represents approximately $29.34M in transactions.



This page (NASDAQ:ALLO) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners